Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CC-115 是一种双重 mTOR/DNA-PK 的抑制剂,IC50分别为 21 nM 和 13 nM,可阻断mTORC1和mTORC2信号通路。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 258 | 现货 | ||
2 mg | ¥ 365 | 现货 | ||
5 mg | ¥ 657 | 现货 | ||
10 mg | ¥ 1,160 | 现货 | ||
25 mg | ¥ 2,430 | 现货 | ||
50 mg | ¥ 3,750 | 现货 | ||
100 mg | ¥ 5,390 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 698 | 现货 |
产品描述 | CC-115 is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). |
靶点活性 | mTOR:21nM, DNA-PK:13 nM |
体外活性 | The IC50 values for CC-115 are >10 μM against a panel of CYP enzymes and >33 μM for the hERG ion channel. When screened in a single point assay at 10 μM against a Cerep receptor and enzyme panel only one target was inhibited >50% (PDE3, IC50 = 0.63 μM). |
体内活性 | CC-115 shows good PK profiles across multiple species with 53%, 76%, and 100% oral bioavailability in mouse, rat, and dog, respectively. CC-115, with favorable physicochemical and pharmacokinetic properties, demonstrates mTOR pathway inhibition and tumor growth inhibition, as well as a good safety profile, suitable for Clinicalal development. |
细胞实验 | Freshly isolated CLL cells are treated with different concentrations of CC-115 for 30 minutes. Subsequently, the cells are exposed to 5-Gy γ-radiation or treated with 10 µg/mL bleomycin (EMD Millipore, Billerica, MA) and incubated for 30 minutes, and cell lysates are made. (Only for Reference) |
别名 | CC 115 |
分子量 | 336.35 |
分子式 | C16H16N8O |
CAS No. | 1228013-15-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 62 mg/mL (184.3 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9731 mL | 14.8655 mL | 29.7309 mL | 74.3273 mL |
5 mM | 0.5946 mL | 2.9731 mL | 5.9462 mL | 14.8655 mL | |
10 mM | 0.2973 mL | 1.4865 mL | 2.9731 mL | 7.4327 mL | |
20 mM | 0.1487 mL | 0.7433 mL | 1.4865 mL | 3.7164 mL | |
50 mM | 0.0595 mL | 0.2973 mL | 0.5946 mL | 1.4865 mL | |
100 mM | 0.0297 mL | 0.1487 mL | 0.2973 mL | 0.7433 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CC-115 1228013-15-7 DNA Damage/DNA Repair PI3K/Akt/mTOR signaling DNA-PK PI3K mTOR DNA-dependent protein kinase CC115 inhibit CC 115 Inhibitor Mammalian target of Rapamycin inhibitor